Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Francesca Satolli

Italy

Research Interests

Explore related searches

Professors in Italy

Articles (17)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (10)

Francesco Bellinato

University of Verona

ITALY

View details

Flavia Manzo Margiotta

University of Pisa

ITALY

View details

Antonio Costanzo

Full Professor of Dermatology

Humanitas University

ITALY

View details

Paolo Gisondi

University of Verona

ITALY

View details

Marco Romanelli

Docenti di ruolo di Ia fascia

University of Pisa

ITALY

View details

Luca Mastorino

Assistan Professor

University of Turin

ITALY

View details

Emanuele Trovato

University of Siena

ITALY

View details

Piergiorgio Malagoli

CHIEF

IRCCS Ospedale San Raffaele

ITALY

View details

Luca Bettolini

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

ITALY

View details

ANNA CAMPANATI

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Francesca Satolli

Research Interests

Explore related searches

Articles (17)

<i>Letter:</i> Effectiveness and Safety of Tralokinumab for the Elderly with Atopic Dermatitis in a Real-World Setting-IL AD.

Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study

JAK Inhibitors in Atopic Dermatitis: Does Weight Matter? A Real-World, Nationwide Retrospective Study: IL-AD (Italian Landscape Atopic Dermatitis)

Switching to brodalumab after failure of IL‐17A inhibitors in psoriatic patients: A real‐life multicentre study

Effectiveness of Tildrakizumab 200 mg in Moderate-to-Severe Plaque Psoriasis: A Multicenter Real-World Study Analyzing Patient Outcomes by Weight, PASI, BMI, and Previous Therapies

Five‐year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real‐world study

Managing the Overlap: Therapeutic Approaches in Patients with Concomitant Psoriasis and Atopic Dermatitis—A Case Series

Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg—IL PSO (Italian Landscape Psoriasis)

Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod

Combined laser assisted treatment for permanent hair removal for skin types I‐V with Alexandrite 755 nm and ND : YAG 1064 nm lasers

Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: A randomized, controlled, assessor‐blinded two‐center trial: The MASCOTTE study

Skin vascular lesions: A new therapeutic option with sequential laser‐assisted technique

Case of a severe vulgaris and foliaceus pemphigus in a young patient treated with rituximab, with subsequent development of chronic urticaria

Blue nevus of the nail: A case report and review

Actinic keratosis: Treatment with imiquimod 3.75%—A comparative study between patients with previous in situ melanoma, patients with invasive melanoma and patients with negative history of melanoma

The COVID ‐19 outbreak and rheumatologic skin diseases

Do acne treatments affect insulin‐like growth factor‐1 serum levels? A clinical and laboratory study on patients with acne vulgaris

Collaborators (10)

Francesco Bellinato

Flavia Manzo Margiotta

Antonio Costanzo

Paolo Gisondi

Marco Romanelli

Luca Mastorino

Emanuele Trovato

Piergiorgio Malagoli

Luca Bettolini

ANNA CAMPANATI

Make your next move.

Francesca Satolli

Research Interests

Explore related searches

Articles (17)

&lt;i&gt;Letter:&lt;/i&gt; Effectiveness and Safety of Tralokinumab for the Elderly with Atopic Dermatitis in a Real-World Setting-IL AD.

Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study

JAK Inhibitors in Atopic Dermatitis: Does Weight Matter? A Real-World, Nationwide Retrospective Study: IL-AD (Italian Landscape Atopic Dermatitis)

Switching to brodalumab after failure of IL‐17A inhibitors in psoriatic patients: A real‐life multicentre study

Effectiveness of Tildrakizumab 200 mg in Moderate-to-Severe Plaque Psoriasis: A Multicenter Real-World Study Analyzing Patient Outcomes by Weight, PASI, BMI, and Previous Therapies

Five‐year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real‐world study

Managing the Overlap: Therapeutic Approaches in Patients with Concomitant Psoriasis and Atopic Dermatitis—A Case Series

Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg—IL PSO (Italian Landscape Psoriasis)

Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod

Combined laser assisted treatment for permanent hair removal for skin types I‐V with Alexandrite 755 nm and ND : YAG 1064 nm lasers

Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: A randomized, controlled, assessor‐blinded two‐center trial: The MASCOTTE study

Skin vascular lesions: A new therapeutic option with sequential laser‐assisted technique

Case of a severe vulgaris and foliaceus pemphigus in a young patient treated with rituximab, with subsequent development of chronic urticaria

Blue nevus of the nail: A case report and review

Actinic keratosis: Treatment with imiquimod 3.75%—A comparative study between patients with previous in situ melanoma, patients with invasive melanoma and patients with negative history of melanoma

The COVID ‐19 outbreak and rheumatologic skin diseases

Do acne treatments affect insulin‐like growth factor‐1 serum levels? A clinical and laboratory study on patients with acne vulgaris

Collaborators (10)

Francesco Bellinato

Flavia Manzo Margiotta

Antonio Costanzo

Paolo Gisondi

Marco Romanelli

Luca Mastorino

Emanuele Trovato

Piergiorgio Malagoli

Luca Bettolini

ANNA CAMPANATI

Make your next move.

<i>Letter:</i> Effectiveness and Safety of Tralokinumab for the Elderly with Atopic Dermatitis in a Real-World Setting-IL AD.